Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mieke Boon (Wilsele, Belgium), Mieke Boon, Frans Merkus, Martine Jaspers, Mark Jorissen. New nasal spray stimulates ciliary activity in vitro. Eur Respir J 2015; 46: Suppl. 59, 2135

Member's Comments

No comment yet.

Related content which might interest you: Intranasal GSK2245035 induces prolonged reductions in nasal responsiveness to allergen Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Impairment of leptin/leptin receptor pathway in nasal epithelium from allergic turbinates Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Influence of nebulized drugs on ciliary activity in vitro Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Evaluation of systemic exposure between two nasal spray formulations of mometasone furoate in healthy subjects Source: Annual Congress 2013 –Treatment of asthma Year: 2013 New inhaled JAK inhibitor LAS194046 inhibits allergen-induced airway inflammation in Brown Norway rats Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 H4 receptor antagonits as a potential medication for upper airway cough syndrom Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 Efficacy and safety of 10 day treatment with the CRTh2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Expression of eotaxins in nasal mucosa of allergic patients after intranasal provocation- preliminary study Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Distribution of mast cells and their interactions with nerve in allergic rhinitis Source: International Congress 2015 – Asthma and lung immunology Year: 2015 A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 New way forward in polyp research; changes in TLR9-expression of apparently healthy nasal mucosa behind polyp growth Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Comparison of three modalities of corticosteroids administration in chronic rhinosinusitis Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 RV-infection modifies DNA-methylation in nasal airway epithelium cell line: Evaluation as a possible asthma trigger Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology Year: 2014